CNS Pharmaceuticals, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CNS Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2026-06-30 was $20.71M.
- CNS Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2024 was $596.30K.
- CNS Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2021 was $4.65M, a 67.03% decline from fiscal 2020.
- CNS Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2020 was $14.12M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $20.71M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $596.30K 10-K · filed 2025-03-31 | |
| 2021-12-31 | $4.65M 10-K · filed 2022-03-03 | |
| 2020-12-31 | $14.12M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |